Cardiothoracic Surgery
News from the FDA/CDC
FDA approves Zephyr endobronchial valve to treat severe emphysema
“This novel device is a less invasive treatment that expands the options available to patients.”
Conference Coverage
Customized airway stents show promise in feasibility trial
SAN DIEGO – Customized airway stents made from 3-D imaging software are feasible and provided compelling outcomes, especially in complex cases...
Conference Coverage
Single Botox treatment cuts AF for 3 years
Three-year follow-up of a pilot study with 60 randomized patients showed one botulinum toxin cardiac treatment linked with a drop in post-CABG AF...
Conference Coverage
Malignant pleural mesothelioma guidelines often are ignored
SAN DIEGO – As many as 32% of patients received no treatment, but their median months of survival weren’t much different than others.
Conference Coverage
MOMENTUM 3 HeartMate 3 LVAD ‘practice changing’
ORLANDO – Landmark trial paves way to much wider use of LVADs as destination therapy.
From the Journals
Reconstruction may reduce chest-related distress in transmasculine youth
There is a need for change in national guidelines, experts say.
From the Journals
Preoperative exercise lowers postoperative lung resection complications
Patients undergoing surgery for lung cancer experienced unique benefits, compared with patients who had surgery for other kinds of cancer.
Conference Coverage
Transcatheter aortic valve-in-ring for mitral disease a winner
DENVER – MITRAL trial breaks new ground for formerly no-hope patients.
Conference Coverage
New frontier in TAVR is bicuspid disease
DENVER – Evolut R valve performs favorably off-label in registry.
Conference Coverage
VAMPIRE 3: Embolic filter for primary PCI reduces MACE
DENVER – Why experts predict the impressive results won’t change U.S. practice.